Delivery Order SPE2DB22D1106-SPE2DB25FFHL5
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $1,410.37 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. This contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The contract has a performance period through March 6, 2024. AmerisourceBergen Drug Corp, operating out of its Corporate Office division in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.30 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Xulane 150-35 microgram/day contraceptive patches (3-pack). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,312.08 to AmerisourceBergen Drug Corp for the supply of Xulane 150-35 mcg/day contraceptive patches (quantity 3). This firm fixed price, competitively awarded delivery order was issued on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1...
- The Defense Logistics Agency awarded a delivery order valued at $2,443.24 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/Day contraceptive patches (3-pack unit) on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract carries firm fixed pricing and was not set-aside. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,377.08 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (three-count package) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,139.48 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-pack) on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches on September 5, 2025, with a ceiling value of $3,164.04 under a firm fixed-price contract type. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $3,988.76 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count). This firm fixed-price, competitively awarded contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.13 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units). This competitively awarded, non-set-aside delivery order reflects firm fixed pricing and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,787.52 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count units) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHL5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,888.42 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive transdermal patch. This competitively awarded, firm fixed-price delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract performs in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. As a critical vendor in the DLA Medical Supply Chain, the company supplies an extensive portfolio of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare systems. The company's federal contract awards demonstrate consistent capability to fulfill diverse medical supply requirements through competitive procurement processes, with delivery orders typically structured as firm fixed-price arrangements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 9/8/25 |